Lunai Bioworks Inc.
LNAINext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for LNAI. That does not mean none is planned.
Get an email about LNAI's next catalysts
Track Lunai Bioworks (LNAI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
2 upcoming events in our data (earnings, partnership).See the timeline
2 upcoming, 1 past
LNAI Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Partnership
Lunai Bioworks signed a definitive collaboration agreement with BrainStorm Therapeutics to develop an integrated roadmap for Parkinson's Disease treatment using AI-driven patient stratification and biomarker development, with initial data readout targeted for the first half of 2027.
SourceHow LNAI's past catalysts played out
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Lunai Bioworks Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Lunai Bioworks Inc. (LNAI) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LNAI biotech catalysts?→
Add LNAI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lunai Bioworks Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.